Evidence map›Paper›PMID 32932963›Full record

ArticleMolecules (Basel, Switzerland)2020

Luminescent Sensor Based on Ln(III) Ternary Complexes for NAD(P)H Detection.

Filip Smrčka, Přemysl Lubal

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Filip SmrčkaDepartment of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
Přemysl LubalDepartment of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
Masaryk University · CZ

Funding

EU COST CA18202 NECTAR ActionEU Horizon 2020 - Nr. 692298 MEDGENETMasaryk University MUNI/A/1424/2019Ministry of Education of the Czech Republic CEITEC 2020 - LQ 1601Ministry of Education of the Czech Republic LTC20044
6 · The paper itself

Abstract

Ln(III) complexes of macrocyclic ligands are used in medicinal chemistry, for example as contrast agents in MRI or radiopharmaceutical compounds, and in diagnostics using fluorescence imaging. This paper is devoted to a spectroscopic study of Ln(III) ternary complexes consisting of macrocyclic heptadentate DO3A and bidentate 3-isoquinolinate (IQCA) ligands. IQCA serves as an efficient antenna ligand, leading to a higher quantum yield and Stokes shift (250-350 nm for Eu, Tb, Sm, Dy in VIS region, 550-650 nm for Yb, Nd in NIR region). The shielding-quenching effect of NAD(P)H on the luminescence of the Ln(III) ternary complexes was investigated in detail and this phenomenon was utilized for the analytical determination of this compound. This general approach was verified through an enzymatic reaction during which the course of ethanol transformation catalyzed by alcohol-dehydrogenase (ADH) was followed by luminescence spectroscopy. This method can be utilized for selective and sensitive determination of ethanol concentration and/or ADH enzyme activity. This new analytical method can also be used for other enzyme systems coupled with NAD(P)H/NAD(P)

Indexed as

LuminescenceAlcohol DehydrogenaseCatalysisContrast MediaEthanolLanthanoid Series ElementsLigandsMolecular StructureNADPOxidation-ReductionRadiopharmaceuticalsSpectrophotometryAlcohol DehydrogenaseContrast MediaEthanolLanthanoid Series ElementsLigandsNADPRadiopharmaceuticalsantenna ligandenzyme probeLn(III) complexesLn(III) luminescence in VIS/NIR rangemacrocyclic ligandsNAD(P)H determination

Identifiers

PMID32932963
PMCPMC7571129
OpenAlexW3086256865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.